Evidence map›Paper›PMID 35268907›Full record

ReviewMaterials (Basel, Switzerland)2022

MXene (Ti

Fouad Damiri, Md Habibur Rahman, Mehrukh Zehravi, Aeshah A Awaji, Mohammed Z Nasrullah, Heba A Gad, Mutasem Z Bani-Fwaz, Rajender S Varma, Mousa O Germoush, Hamdan S Al-Malky and 4 more

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Recent Trends in Biomedical Applications of CuInternational journal of nanomedicine · 2025
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Fouad DamiriLabortory of Biomolecules and Organic Synthesis (BioSynthO), Department of Chemistry, Faculty of Sciences Ben M'Sick, University Hassan II of Casablanca, Casablanca 20000, Morocco.ORCID 0000-0002-5478-8142
Md Habibur RahmanDepartment of Global Medical Science, Wonju College of Medicine, Yonsei University, Wonju 26426, Gangwon, Korea.ORCID 0000-0001-6099-5693
Mehrukh ZehraviDepartment of Clinical Pharmacy Girls Section, Prince Sattam Bin Abdul Aziz University Alkharj, Alkharj 11942, Saudi Arabia.
Aeshah A AwajiDepartment of Biology, Faculty of Science, University College of Taymaa, University of Tabuk, Tabuk 71491, Saudi Arabia.
Mohammed Z NasrullahDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-4755-0742
Heba A GadDepartment of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia.ORCID 0000-0002-6465-3102
Mutasem Z Bani-FwazDepartment of Chemistry, College of Science, King Khalid University, Abha 61413, Saudi Arabia.ORCID 0000-0003-0426-1657
Rajender S VarmaRegional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute, Palacky University, Šlechtitelů 27, 783 71 Olomouc, Czech Republic.ORCID 0000-0001-9731-6228
Mousa O GermoushBiology Department, College of Science, Jouf University, Sakaka 72388, Saudi Arabia.
Hamdan S Al-MalkyRegional Drug Information Center, Ministry of Health, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-1825-8304
Amany A SayedZoology Department, Faculty of Science, Cairo University, Giza 12613, Egypt.
Satish RojekarDepartment of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai 400019, India.
Mohamed M Abdel-DaimDepartment of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia.ORCID 0000-0002-4341-2713
Mohammed BerradaLabortory of Biomolecules and Organic Synthesis (BioSynthO), Department of Chemistry, Faculty of Sciences Ben M'Sick, University Hassan II of Casablanca, Casablanca 20000, Morocco.ORCID 0000-0003-1809-2954

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymeric nanocomposites have been outstanding functional materials and have garnered immense attention as sustainable materials to address multi-disciplinary problems. MXenes have emerged as a newer class of 2D materials that produce metallic conductivity upon interaction with hydrophilic species, and their delamination affords monolayer nanoplatelets of a thickness of about one nm and a side size in the micrometer range. Delaminated MXene has a high aspect ratio, making it an alluring nanofiller for multifunctional polymer nanocomposites. Herein, we have classified and discussed the structure, properties and application of major polysaccharide-based electroactive hydrogels (hyaluronic acid (HA), alginate sodium (SA), chitosan (CS) and cellulose) in biomedical applications, starting with the brief historical account of MXene's development followed by successive discussions on the synthesis methods, structures and properties of nanocomposites encompassing polysaccharides and MXenes, including their biomedical applications, cytotoxicity and biocompatibility aspects. Finally, the MXenes and their utility in the biomedical arena is deliberated with an eye on potential opportunities and challenges anticipated for them in the future, thus promoting their multifaceted applications.

Indexed as

biomedicalMXenes (Ti3C2Tx)nanocompositesnanomaterialsnanotechnology

Identifiers

PMID35268907
PMCPMC8911478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.